Analysis of sepsis in allogeneic bone marrow transplant recipients: A single-center study

Journal of Infection and Chemotherapy

Volumn 9, Issue 3, 2003, Pages 238-242

  Mitsui, Hideki ^a   Karasuno, Takahiro ^a   Santo, Taisuke ^a   Fukushima, Kentaro ^a   Matsunaga, Hitomi ^a   Nakamura, Hiroyuki ^a   Hiraoka, Akira ^a  

^a Osaka Medical Center for Cancer   (Japan)

Author keywords

Bone marrow transplantation; Selective gut decontamination; Sepsis; Staphylococcus epidermidis

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; LOMEFLOXACIN; MELPHALAN; METHOTREXATE; NYSTATIN; STEROID; TACROLIMUS; TOBRAMYCIN; VANCOMYCIN;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; BLOOD CULTURE; CAUSE OF DEATH; CONTROLLED STUDY; DONOR; DRUG UTILIZATION; FECES CULTURE; FEMALE; GRAM NEGATIVE BACTERIUM; GUT DECONTAMINATION; HLA MATCHING; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PROGNOSIS; RECIPIENT; REVIEW; RISK FACTOR; SCHOOL CHILD; SEPSIS; STOMATITIS; TECHNIQUE; URINE CULTURE;

EID: 0142058492     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-003-0252-8     Document Type: Article

References (9)

1. Williamson ECM, Millar MR, Steward CG, Cornish JM, Foot ABM, Oakhill A, et al. Infections in adults undergoing unrelated bone marrow transplantation. Br J Haematol 1999;104:560-8.
2. Sparrelid E, Hagglund H, Remberger M, Ringden O, Lonnqvist B, Ljungman P. Bacteraemia during the aplastic phase after bone marrow transplantation is associated with early death from invasive fungal infection. Bone Marrow Transplant 1998;22:795-800.
3. Schots R, Kaufman L, Riet IV, Lacor P, Trullemans F, Waele MD, et al. Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality. Bone Marrow Transplant 1998;22:79-85.
4. Yuen KY, Woo PCY, Hui CH, Luk WK, Chen FE, Lie AKW, et al. Unique risk factors for bacteraemia in allogeneic bone marrow transplant recipients before and after engraftment. Bone Marrow Transplant 1998;21:1137-43.
5. Rotstein C, Higby D, Killion K, Powell E. Relationship of surveillance cultures to bacteremia and fungemia in bone marrow transplant recipients with Hickman or Broviac catheters. J Surg Oncol 1988;39:154-8.
6. Donnelly JP. Bacterial complications of transplantation: diagnosis and treatment. J Antimicrob Chemother 1995;36(Suppl B):59-72.
7. Schots R, Trullemans F, Van Riet I, Kaufman L, Hafsia A, Meddeb B, et al. The clinical impact of early gram-positive bacteremia and the use of vancomycin after allogeneic bone marrow transplantation. Transplantation 2000;69:1511-4.
8. Riley DK, Pavia AT, Beatty PG, Denton D, Carroll KC. Surveillance cultures in bone marrow transplant recipients: worthwhile or wasteful? Bone Marrow Transplant 1995;15:469-73.
9. Antin JH, Lee SJ, Neuberg D, Alyea E, Soiffer RJ, Sonis S, et al. A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation. Bone Marrow Transplant 2002;29:373-7.